Product Description: Bivalirudin, a peptide anticoagulant, is a direct thrombin inhibitor for anticoagulation in the setting of invasive cardiology, particularly percutaneous coronary intervention[1][2].
Applications: Neuroscience-Neuromodulation
Formula: C98H138N24O33
Citations: Compos B Eng. 2024 Aug 15./Allergy. 2022 Jan 7./Antiviral Res. 2023 Apr 17;105606./Compos Part B-Eng. 1 April 2022, 109702./Elife. 2022 Mar 23:11:e77444./International Journal of Automation Technology. 2020 Jan./J Am Soc Mass Spectrom. 2020 Jul 5./J Clin Pathol. 2019 Dec;72(12):817-824.
References: [1]Bates ER, et al. Bivalirudin: an anticoagulant option for percutaneous coronary intervention.Expert Rev Cardiovasc Ther. 2004 Mar;2(2):153-62./[2]André P, et al. Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis.Circulation. 2003 Nov 25;108(21):2697-703.
CAS Number: 128270-60-0
Molecular Weight: 2180.29
Compound Purity: 99.97
Research Area: Cardiovascular Disease
Solubility: H2O : 10 mg/mL (ultrasonic)
Target: Thrombin
Deutsch
English
